Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 1;101(1):303-318.
doi: 10.1152/physrev.00024.2020. Epub 2020 Sep 24.

Pregnancy and COVID-19

Affiliations
Review

Pregnancy and COVID-19

Elizabeth A N Wastnedge et al. Physiol Rev. .

Abstract

There are many unknowns for pregnant women during the coronavirus disease 2019 (COVID-19) pandemic. Clinical experience of pregnancies complicated with infection by other coronaviruses e.g., Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome, has led to pregnant woman being considered potentially vulnerable to severe SARS-CoV-2 infection. Physiological changes during pregnancy have a significant impact on the immune system, respiratory system, cardiovascular function, and coagulation. These may have positive or negative effects on COVID-19 disease progression. The impact of SARS-CoV-2 in pregnancy remains to be determined, and a concerted, global effort is required to determine the effects on implantation, fetal growth and development, labor, and neonatal health. Asymptomatic infection presents a further challenge regarding service provision, prevention, and management. Besides the direct impacts of the disease, a plethora of indirect consequences of the pandemic adversely affect maternal health, including reduced access to reproductive health services, increased mental health strain, and increased socioeconomic deprivation. In this review, we explore the current knowledge of COVID-19 in pregnancy and highlight areas for further research to minimize its impact for women and their children.

Keywords: COVID-19; neonatal outcomes; pathophysiology; placenta; pregnancy.

PubMed Disclaimer

Conflict of interest statement

H. O. D. Critchley has clinical research support for laboratory consumables and staff from Bayer AG and provides consultancy advice (but with no personal remuneration) for Bayer AG, PregLem SA, Gedeon Richter, Vifor Pharma UK, AbbVie, and Myovant Sciences. H. O. D. Critchley receives royalties from UpToDate for an article on abnormal uterine bleeding. No conflicts of interest, financial or otherwise, are declared by any of the other authors.

Figures

None
Graphical abstract

References

    1. Abdoli A, Falahi S, Kenarkoohi A, Shams M, Mir H, Jahromi MAM. The COVID-19 pandemic, psychological stress during pregnancy, and risk of neurodevelopmental disorders in offspring: a neglected consequence. J Psychosom Obstet Gynaecol 41: 247–248, 2020. doi:10.1080/0167482X.2020.1761321. - DOI - PubMed
    1. Ahmed I, Azhar A, Eltaweel N, Tan BK. First COVID-19 maternal mortality in the UK associated with thrombotic complications. Br J Haematol 190: e37–e38, 2020. doi:10.1111/bjh.16849. - DOI - PMC - PubMed
    1. Al-Haddad BJS, Jacobsson B, Chabra S, Modzelewska D, Olson EM, Bernier R, Enquobahrie DA, Hagberg H, Östling S, Rajagopal L, Adams Waldorf KM, Sengpiel V. Long-term risk of neuropsychiatric disease after exposure to infection in utero. JAMA Psychiatry 76: 594–602, 2019. doi:10.1001/jamapsychiatry.2019.0029. - DOI - PMC - PubMed
    1. Alhusen JL, Ray E, Sharps P, Bullock L. Intimate partner violence during pregnancy: maternal and neonatal outcomes. J Womens Health (Larchmt) 24: 100–106, 2015. doi:10.1089/jwh.2014.4872. - DOI - PMC - PubMed
    1. Amirchaghmaghi E, Taghavi SA, Shapouri F, Saeidi S, Rezaei A, Aflatoonian R. The role of Toll-like receptors in pregnancy. Int J Fertil Steril 7: 147–154, 2013. - PMC - PubMed

Publication types